The role of IRX3 in pancreatic development is in conflict with the knowledge that most obese individuals display an increase in pancreatic beta cell mass as a compensatory response to the peripheral insulin resistance that co-exists [56] and the knowledge that most previously-identified obesity genes are involved in neuronally-mediated central energy balance [42]. Here, IRX3 is linked to obesity due to melanocortin 4 receptor deficiency.